SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Aronex Pharma (ARNX)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Dr. Voodoo who wrote (308)9/28/1999 11:29:00 AM
From: ProfSam  Read Replies (1) of 320
 
Deficiencies
in my unmedically-qualified opinion, can be:
1. mathematical/statistical processing errors; like errors in
classifying data/grouping results, methodology errors
2. clinical errors; like mistakes in the lab, dosages, results
measurements
I understand (1.), but I wish a med tech could comment on (2.), because the Mehta group is hinting at additional clinical trials for Atragen.
ARNX was saying they expect to be back at FDA by the end of the year. The above are truths, to go further would be speculation on my part. I am in a "digesting" phase right now....hope I don't get sick.
good luck, Sam
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News